Alethia Young
Director of Finance/CFO at BICYCLE THERAPEUTICS PLC
Net worth: 678 919 $ as of 2024-03-30
Profile
Alethia Rene Young is currently an Independent Director at PTC Therapeutics, Inc., an Independent Director at Pacira Biosciences, Inc., a Director at Build NYC Resource Corp., and the Chief Financial Officer at Bicycle Therapeutics Plc.
Previously, she worked as a Research Analyst at Credit Suisse Securities (USA) LLC, a Healthcare Research Associate at JPMorgan Investment Management, Inc., a Research Analyst at Deutsche Bank Securities, Inc., the Senior Biotech Analyst & Research Head at Cantor Fitzgerald & Co., the President at Marwood Group LLC, and the Chief Financial & Accounting Officer at Graphite Bio, Inc. She received her undergraduate degree from Duke University in 2000.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
PTC THERAPEUTICS, INC.
0.02% | 2024-02-14 | 13,067 ( 0.02% ) | 380 119 $ | 2024-03-30 |
2024-01-01 | 12,000 ( 0.04% ) | 298 800 $ | 2024-03-30 | |
-.--% | 2024-01-31 | 0 ( -.--% ) | - $ | 2024-03-30 |
PACIRA BIOSCIENCES, INC.
-.--% | 2023-10-05 | 0 ( -.--% ) | - $ | 2024-03-30 |
Alethia Young active positions
Companies | Position | Start |
---|---|---|
PTC THERAPEUTICS, INC. | Director/Board Member | 2022-06-08 |
BICYCLE THERAPEUTICS PLC | Director of Finance/CFO | 2023-07-16 |
PACIRA BIOSCIENCES, INC. | Director/Board Member | 2023-10-09 |
Build NYC Resource Corp.
Build NYC Resource Corp. Miscellaneous Commercial ServicesCommercial Services Build NYC Resource Corp. is an economic development agency that assists organizations and exempt facilities in accessing debt through tax-exempt bond financing for real estate capital investments. The non-profit company is based in New York, NY and has subsidiaries in the United States. | Director/Board Member | - |
Former positions of Alethia Young
Companies | Position | End |
---|---|---|
LENZ THERAPEUTICS, INC. | Director of Finance/CFO | 2023-06-29 |
Cantor Fitzgerald & Co.
Cantor Fitzgerald & Co. Investment Banks/BrokersFinance Cantor Fitzgerald & Co. is the investment bank and brokerage subsidiary of CFS CF & Co. I Holdings LP, which is owned by Cantor Fitzgerald LP in the US. The firm was founded by Bernie Gerald Cantor and John Fitzgerald in 1945. Headquartered in New York City, Cantor Fitzgerald offers clients a global, multi-asset prime brokerage platform with a focus on the quality middle market. | Director of Research - Equity | 2022-03-31 |
Credit Suisse Securities (USA) LLC (Broker)
Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world. | Analyst-Equity | 2018-07-31 |
Deutsche Bank Securities, Inc.
Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Analyst-Equity | 2015-07-30 |
Marwood Group LLC
Marwood Group LLC Investment ManagersFinance Founded in 2000 by John T. Moore and Edward M. Kennedy, Jr., Marwood Group LLC is a healthcare advisory and financial services firm headquartered in New York City. The firm is a subsidiary of Marwood Group & Co. USA LLC | President | 2009-02-26 |
Training of Alethia Young
Duke University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
PTC THERAPEUTICS, INC. | Health Technology |
PACIRA BIOSCIENCES, INC. | Health Technology |
BICYCLE THERAPEUTICS PLC | Health Technology |
Private companies | 7 |
---|---|
Credit Suisse Securities (USA) LLC (Broker)
Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world. | Finance |
JPMorgan Investment Management, Inc.
JPMorgan Investment Management, Inc. Investment ManagersFinance JPMorgan Investment Management, Inc. (JPMIM) is a global, SEC-registered investment advisor headquartered in New York City. The firm was founded in 2000 as the result of Chase Manhattan's purchase of Robert Fleming Holdings and the subsequent merger of Chase and JPMorgan. In January 2010, JPMorgan Investment Advisors merged into JP Morgan Investment Management. JPMIM is a subsidiary of JPMorgan Asset Management Holdings, Inc., ultimately owned by JPMorgan Chase & Co. (NYSE: JPM). The firm primarily provides investment advisory services to both US and non-US institutional and retail clients. | Finance |
Deutsche Bank Securities, Inc.
Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Finance |
Cantor Fitzgerald & Co.
Cantor Fitzgerald & Co. Investment Banks/BrokersFinance Cantor Fitzgerald & Co. is the investment bank and brokerage subsidiary of CFS CF & Co. I Holdings LP, which is owned by Cantor Fitzgerald LP in the US. The firm was founded by Bernie Gerald Cantor and John Fitzgerald in 1945. Headquartered in New York City, Cantor Fitzgerald offers clients a global, multi-asset prime brokerage platform with a focus on the quality middle market. | Finance |
Marwood Group LLC
Marwood Group LLC Investment ManagersFinance Founded in 2000 by John T. Moore and Edward M. Kennedy, Jr., Marwood Group LLC is a healthcare advisory and financial services firm headquartered in New York City. The firm is a subsidiary of Marwood Group & Co. USA LLC | Finance |
Build NYC Resource Corp.
Build NYC Resource Corp. Miscellaneous Commercial ServicesCommercial Services Build NYC Resource Corp. is an economic development agency that assists organizations and exempt facilities in accessing debt through tax-exempt bond financing for real estate capital investments. The non-profit company is based in New York, NY and has subsidiaries in the United States. | Commercial Services |
Graphite Bio, Inc.
Graphite Bio, Inc. BiotechnologyHealth Technology Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Alethia Young